Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma

Indian Journal of Pathology and Microbiology

Volumn 51, Issue 2, 2008, Pages 167-171

  Geramizadeh, Bita ^a   Ravanshad, Mahmoud ^a   Rahsaz, Marjan ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Immunohistochemistry; Oncocytoma; Renal cell carcinoma; Tumors

Indexed keywords

CD18 ANTIGEN; CD8 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 20; CYTOKERATIN 7; CYTOKERATIN 8; FERRIC HYDROXIDE; MONOCLONAL ANTIBODY; VIMENTIN;

ADULT; AGED; ARTICLE; CLEAR CELL CARCINOMA; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; ONCOCYTOMA; PAPILLARY CARCINOMA; SPINDLE CELL CARCINOMA;

ADENOMA, OXYPHILIC; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARCINOMA, RENAL CELL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; KERATIN-7; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; NEPRILYSIN; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 46949111492     PISSN: 03774929     EISSN: None     Source Type: Journal    
DOI: 10.4103/0377-4929.41641     Document Type: Article

References (19)

1. Kovacs G, Akhtar M, Beck with BJ. The Heidelberg classification of renal cell tumor. J Pathol 1997;183:131-3.
2. Eble JN, Sauter G, Epstein JI, et al. World health organization classification of tumors. Pathology and genetics of tumors of urinary system and male genital organs. Lyon, France: IARC Press: 2004.
3. Crotty TB, Farrow GM, Leiber MM. Chromophobe renal cell carcinoma, clinicopathologic feature of 50 cases. J Urol 1995;154:964-7.
4. Cochand-Priollet B, Molinie V, Bougaran J, Bouvier R, Dauge-Geffroy MC, Deslignieres S, et al. Renal chromophobe cell carcinoma and oncocytoma a comparative morphologic, histological and immunohistochemial study of 124 cases. Arch Pathol Lab Med 1997;121:181-6.
5. Langer C, Wegscheider BJ, Ratschek M, Schips L, Zigeuner R. Keratin immunohistochemistry in renal cell carcinoma subtypes and renal oncocytomas: A systematic analysis of 223 tumors. Virchows Arch 2004;444:127-34.
6. Wang HY, Mills ES. Kit and RCC are useful in distinguishing chromophbe renal cell carcinoma from the granular variant of clear cell renal carcinoma. Am J Surg Pathol 2005;29:640-6.
7. Mazal PR, Exner M, Haietel A, Krieger S, Thomson RB, Aronson PS, Susani M. Expression of Kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma. Hum Pathol 2005;36:22-8.
8. Mai KT, Burns BF. chromophobe cell carcinoma and renal cell neoplasm with mucin-like changes. Acta Histochem 2000;102:103-13.
9. Skinnider BF, Flope AL, Hennigar RA, Lim SD, Cohen C, Tomboli P, et al. Distribution of cytokeratins and Vimentin in adult renal neoplasms and normal renal tissue. Am J Surg Pathol 2005;29:747-54.
10. Mathers ME, Pollock AM, Marshc Donnell Mo. Cyktokeratin 7: A useful adjunct in diagnosis of chromophobe renal cell carcinoma. Histopathology 2002;40:563-7.
11. Kuroda N, Toi M, Nakamura H, Miyazaki E, Haysahi Y, Yamamoto M, et al. Immunohistochemical identification of intracytoplasmic lumen by cytokeratin typing may differentiate renal oncocytoma from chromophobe renal cell carcinoma. Histol Histopathol 2004;19:23-8.
12. Leroy X, Moukassa D, Copin MC, Saint F, Mazeman E, Gosselin B. Utility of cytokeratin 7 for distinguishing chromophobe renal cell carcinoma from renal oncocytoma. Eur Urol 2000;37:484-7.
13. Abrahams NA, MacLennan GT, Khoury JD, Ormsby AH, Tamboli P, Doglioni C, et al. Chromophobe renal cell carcinoma: A comparative study of histological immunohistochemical and ultrastructural features using high through put tissue microoarray. Histopathology 2004;45:593-602.
14. Dai L, Lu XH, Li ZH, Li R, Liu H, Liu Yl, et al. Value of special stain and immunohistochemistry in the diagnosis of renal neoplasm. Zhonghua Bing Li Xue Za Zhi 2004;33:140-2.
15. Avery AK, Beckstead J, Renshow AA, Christopher L, Corless L. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasia. Am J Surg Pathol 2000;24:203-10.
16. Pan CC, Chen PC, Ho DM. The diagnostic utility of MOC31, Ber Ep4, RCC marker and CD10 in classification of renal cell carcinoma and oncocytoma. Histopathology 2004;45:452-9.
17. Yang B, Ali SZ, Rosenthal DI. CD10 facilitates the diagnosis of metastatic renal cell carcinoma from primary adrenal cortical neoplasm in adrenal fine-needle aspiration. Diagn Cytopathol 2002:27:149-52.
18. Langner C, Ratschek M, Rehak P, Tsybrovskyy O, Zigeuner R. CD10 is a diagnostic and prognostic marker in renal malignancy. Histopathology 2004;45:460-7.
19. Skinnider BF, Jones EC. Renal oncocytoma and chromophobe renal cell carcinoma. A comparison of colloidal iron staining and electron microscopy. Am J Clin Pathol 1999;111:796-803.